Skip to main content
Clinical Trials/IRCT2015090823942N1
IRCT2015090823942N1CompletedPhase 4

Evaluation of total serum magnesium concentrations in neonatal hyperbilirubinemia before and after phototherapy

Vice-chancellor for Research of Zahedan University of Medical Sciences0 sites90 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
90

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 day to 15 days (—)
Sex
All

Inclusion Criteria

  • 90 otherwise-healthy term newborns with nonhemolytic hyperbilirubinemia during the first 4 weeks of life according to their age and standard graphs
  • Exclusion criteria:Those neonates with anemia(Hb<8 ); symptoms in favor of hemolysis (ABO or Rh mismatch, G6PD deficiency, positive direct coombs test); history of Mg sulfate administration in mother and symptoms/signs in favor of infections; metabolic and endocrine disorders

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice-chancellor for Research of Zahedan University of Medical Sciences

Similar Trials

Total serum magnesium in the icteric... | Clinical Trial